Healthcare Services

Metabolomics Market Insights Highlighting Growth Opportunities Through 2030

April 23, 2026April 26, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Large Will The Metabolomics Market Be By 2030 Compared To Its 2026 Market Size?

The metabolomics market has demonstrated rapid expansion in its size over recent years. It is anticipated to grow from $4.17 billion in 2025 to $4.9 billion in 2026, achieving a compound annual growth rate (CAGR) of 17.5%. The historical growth of this market can be ascribed to several key drivers, including growing biomarker discovery research, increasing mass spectrometry adoption, a rise in cancer metabolism studies, expanding chromatography system usage, and the growth in metabolite profiling techniques.

The metabolomics market size is poised for significant expansion in the upcoming years, with projections indicating a rise to $9.29 billion by 2030, exhibiting a robust compound annual growth rate (CAGR) of 17.3%. This expansion during the forecast period is primarily driven by progress in bioinformatics tools, a heightened focus on personalized medicine, increasing requirements for nutrigenomics applications, a surge in metabolic pathway research, and broader integration with clinical diagnostics. Prominent trends anticipated within this period involve the convergence of precision medicine with metabolomic profiling, the proliferation of cloud-based metabolomics data platforms, AI-powered metabolite pattern recognition, increased automation in high-throughput metabolomics workflows, and real-time metabolic monitoring enabled by IoT.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2497&type=smp

What Factors Are Contributing To The Growth Of The Metabolomics Market?

The increasing occurrence of cancer is projected to fuel expansion in the metabolomics market in the future. Cancer refers to a collection of illnesses characterized by the unchecked proliferation of aberrant cells, their invasion into tissues, and potential metastasis to different bodily regions. This rise in cancer cases stems from an aging demographic, given that old age represents the primary risk factor for developing most cancers, with a majority of diagnoses found in people aged above 65. Metabolomics assists cancer investigations by offering a detailed view of metabolic alterations within tumor cells, thereby aiding in early diagnosis, unraveling disease pathways, and pinpointing possible therapeutic interventions. For example, the World Health Organization, an international body based in Switzerland focused on global health policy and public health, reported in February 2024 a forecast of over 35 million new cancer cases by 2050. This represents a 77% surge from the approximate 20 million cases recorded in 2022. Consequently, the growing incidence of cancers is stimulating the expansion of the metabolomics market.

How Is The Metabolomics Market Broken Down By Segment Categories?

The metabolomics market covered in this report is segmented –

1) By Product And Service: Metabolomics Instruments, Metabolomics Bioinformatics Tools And Services

2) By Indication: Cancer, Cardiovascular Disorders, Neurological Disorders, Inborn Errors Of Metabolism, Other Indications

3) By Application: Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics, Personalized Medicine, Other Applications

Subsegments:

1) By Metabolomics Instruments: Chromatography Instruments (Gas Chromatography, Liquid Chromatography), Mass Spectrometry Instruments (LC-MS, GC-MS), NMR Instruments (Nuclear Magnetic Resonance)

2) By Metabolomics Bioinformatics Tools And Services: Software Tools (Data Analysis, Statistical Tools, Modeling Tools), Database Services (Metabolomic Databases), Consulting Services (Data Interpretation, Analytical Support), Training And Support Services

What Trends Are Shaping The Future Of The Metabolomics Market?

Major companies operating within the metabolomics market are focusing on implementing Integrated Bioinformatics Platforms to enhance the interpretation of intricate metabolomic data, thus fostering progress in personalized medicine, biomarker discovery, and disease comprehension. An Integrated Bioinformatics Platform is a comprehensive software solution that consolidates various bioinformatics tools and databases to streamline the analysis and interpretation of biological data. Researchers can cross-reference metabolomics data with Metabolon’s accurate biochemical pathway maps, which aids in revealing biological processes and disease mechanisms. For example, in February 2024, Metabolon, Inc., a US-based company, launched Metabolon’s bioinformatics platform. The Integrated Bioinformatics Platform includes Biomarker Lenses, allowing users to apply sophisticated analytical filters to focus on metabolites associated with specific pathways or diseases, thereby facilitating a more directed exploration of metabolomic data. This platform also provides functionalities for conducting statistical analyses like T-tests and ANOVAs, empowering researchers to construct and compare statistical models, manage metadata, and visualize results clearly.

Which Players Are Present In The Metabolomics Market Space?

Major companies operating in the metabolomics market are Human Metabolome Technologies Inc., Metabolon Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Agilent Technologies Inc., Thermo Fisher Scientific Inc., Waters Corporation, Biocrates Life Sciences AG, Shimadzu Corporation, Danaher Corporation, PerkinElmer Inc., LECO Corporation, Phenomenome Discoveries Inc., AB Sciex, BG Medicine Inc., Chenomx Inc., Creative Proteomics, Evotec A.G, Merck kgaA, Charles River Laboratories International Inc., Metabowerke GmbH, Metabolomic Diagnostics, Phenomenex Inc.

Get The Full Metabolomics Market Report:

https://www.thebusinessresearchcompany.com/report/metabolomics-global-market-report

Which Region Leads The Metabolomics Market In Overall Market Size?

North America was the largest region in the metabolomics market in 2025. Western Europe was the second largest region in the metabolomics market. The regions covered in the metabolomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Metabolomics Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/metabolomics-global-market-report

Browse Through More Reports Similar to the Global Metabolomics Market 2026, By The Business Research Company

Biochemistry Analyzer Market Report 2026

https://www.thebusinessresearchcompany.com/report/biochemistry-analyzer-global-market-report

Metabolomics Market Report

https://www.thebusinessresearchcompany.com/report/metabolomics-global-market-report

Point Of Care Glucose Testing Market Report

https://www.thebusinessresearchcompany.com/report/point-of-care-glucose-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795